Atai stock forecast.

2023 Outlook Reports. ... The small-cap market has been invaded by a flurry of psychedelics stocks to watch thanks to new company launches. ... ATAI Life Sciences is a clinical-stage biopharma ...NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company focused on mental health ...3. 4. 2023. ... As atai currently has a stock price of $1.83 and a market cap of $304 million. Meaning it is trading at a 14% discount. And again, that ...View a financial market summary for ATAI including stock price quote, trading volume, volatility, options volume, statistics, and other important company ...

Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...

RPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

18. 6. 2021. ... Atai Life Sciences, a biotech company that uses psychedelics to treat ... Stock ScreenerNEW! Market Forecast · Options Investing; Subscribe; Sign ...This stake is worth roughly $98M as of Tuesday, March 28, based on COMPASS Pathways’ closing price of $10.23/share on that day. You can find atai’s filed 10-K from last Friday here. With ...The ATA Inc. stock price gained 7.69% on the last trading day (Friday, 1st Dec 2023), rising from $1.04 to $1.12. During the last trading day the stock fluctuated 12.20% from a day low at $1.03 to a day high of $1.15. The price has risen in 5 of the last 10 days and is up by 0.9% over the past 2 weeks. Volume fell on the last day by -2 million ...STRO Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Sutro Biopharma in the last 3 months. The average price target is $13.40 with a high forecast of $17.00 and a low forecast of $10.00. The average price target represents a 396.30% change from the last price of $2.70.The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors. 7 Stocks That AI Predicts Will Soar in 2024 InvestorPlace. Artificial intelligence (AI) has become an invaluable ...

Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...

Analyst Price Forecast Suggests 644.36% Upside As of August 2, 2023, the average one-year price target for ATAI Life Sciences N.V. is 12.51. The forecasts range from a low of 5.15 to a high of $22.05.

ACIU Stock 12 Months Forecast. Based on 2 Wall Street analysts offering 12 month price targets for AC Immune SA in the last 3 months. The average price target is $16.00 with a high forecast of $16.00 and a low forecast of $16.00. The average price target represents a 417.80% change from the last price of $3.09.U.S. Television Show Ratings Ranking. Ranking is based on ratings data as of Monday, November 20, 2023. The audience figures are derived from the latest Nielsen daily, weekly, or monthly P2+ program audience averages, whichever is the most recently available within the past seven-day window.These forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ...That said, analysts are starting to come around on ATAI. H.C. Wainwright biotech analyst Patrick Trucchio maintained a "buy" rating on Atai in early October, with a price target of $20. Its ...View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.21. 6. 2023. ... Recent price, YTD Change, Market value (mil), Average price target, Implied ... ATAI Life Sciences / ATAI, 1.78, -31.2, 303.8, 12.30, 593. Caribou ...ATAI Stock. USD 1.87 0.04 2.09%. ATAI Life Sciences stock price prediction is an act of determining the future value of ATAI Life shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of ATAI Life's future price could yield a significant profit.

Company Description. ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive …atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of ...13.80 0.00 0.00% The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —. Analyst rating Based on 7 analysts giving stock …WebThese forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ...Find the latest Sorrento Therapeutics, Inc. (SRNEQ) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...atai Life Sciences N.V. - Buy. Zacks' proprietary data indicates that atai Life Sciences N.V. is currently rated as a Zacks Rank 2 and we are expecting an above average return from the ATAI shares ...Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.

Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.

-15.00(-0.11%) Russell 2000 1,807.50 +11.96(+0.67%) Crude Oil 75.54 -1.56(-2.02%) Gold 2,003.00 +10.20(+0.51%) Atai Life Sciences N.V. (ATAI) NasdaqGM - NasdaqGM Real Time Price. Currency in...Find real-time TLRY - Tilray Brands Inc stock quotes, company profile, news and forecasts from CNN Business.According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst …Find the latest Global Partners LP (GLP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Based on 3 Wall Street analysts offering 12 month price targets for SomaLogic in the last 3 months. The average price target is $2.40 with a high forecast of $2.50 and a low forecast of $2.30. The average price target represents a -2.04% change from the last price of $2.45. Highest Price Target $2.50. Average Price Target $2.40.7 Wall Street research analysts have issued twelve-month price targets for Mind Medicine (MindMed)'s shares. Their MNMD share price targets range from $7.00 to $75.00. On average, they anticipate the company's share price to reach $25.43 in the next year. This suggests a possible upside of 684.8% from the stock's current price.The average Compass stock price prediction forecasts a potential upside of 35.39% from the current COMP share price of $2.43. What is COMP's forecast return on equity ...

Find real-time TLRY - Tilray Brands Inc stock quotes, company profile, news and forecasts from CNN Business.

NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. Are investors shorting NeuBase Therapeutics? NeuBase Therapeutics saw a decrease in short interest in the month of October.

The company's stock is trading at about 20 cents per share as of Oct. 24. Cybin Inc . ( CYBN) Cybin, a Canadian psychedelic drug developer that produces treatments for depression, anxiety and ...LPTX Stock 12 Months Forecast. Based on 3 Wall Street analysts offering 12 month price targets for Leap Therapeutics in the last 3 months. The average price target is $10.00 with a high forecast of $12.00 and a low forecast of $7.00. The average price target represents a 249.65% change from the last price of $2.86.A. While ratings are subjective and will change, the latest ATAI Life Sciences ( ATAI) rating was a reiterated with a price target of $0.00 to $20.00. The current price ATAI Life Sciences ( ATAI ...Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.Find the latest Atai Life Sciences N.V. (ATAI) stock quote, history, news and other vital information to help you with your stock trading and investing. According to the issued ratings of 4 analysts in the last year, the consensus rating for Atai Life Sciences stock is Buy based on the current 4 buy ratings for ATAI. The average twelve-month price prediction for Atai Life Sciences is $12.80 with a high price target of $20.00 and a low price target of $9.00. Learn more on ATAI's analyst rating ...Atai Capital believes showing returns net of a 1.50% management fee better reflects actual performance as of 07/12/2023 since no account that Atai Capital currently manages is charged a fee more ...Price target. 13.80 0.00 0.00%. The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —.

Company Description. ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive …CMPS Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for COMPASS Pathways in the last 3 months. The average price target is $50.17 with a high forecast of $120.00 and a low forecast of $21.00. The average price target represents a 832.53% change from the last price of $5.38.Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Digital Turbine Inc have a median target of 5.50, with a high estimate of 12.00 and a low estimate of 5.00. The median ...Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...Instagram:https://instagram. how to start trading cryptocurrencyhydreight pharmacytricare dental insurance for retireeseric becker Find the latest AFC Gamma, Inc. (AFCG) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ... buy stocks direct from companypll stock forecast Stock analysis for ATAI Life Sciences NV (ATAI:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Find real-time NEE - Nextera Energy Inc stock quotes, company profile, news and forecasts from CNN Business. stock xlv Nov 29, 2023 · Atai Life Sciences Stock Price, News & Analysis (NASDAQ:ATAI) $1.10 +0.01 (+0.92%) (As of 11/24/2023 ET) Compare Today's Range $1.08 $1.12 50-Day Range $1.06 $1.52 52-Week Range $1.05 $3.65 Volume 272,978 shs Average Volume 997,775 shs Market Capitalization $182.61 million P/E Ratio N/A Dividend Yield N/A Price Target $12.80 CMPS Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for COMPASS Pathways in the last 3 months. The average price target is $50.17 with a high forecast of $120.00 and a low forecast of $21.00. The average price target represents a 832.53% change from the last price of $5.38.